BDMD

Baird Medical Investment Holdings Ltd Ordinary Share

5.59 USD
+0.34
6.48%
At close Apr 17, 4:00 PM EDT
1 day
6.48%
5 days
15.50%
1 month
-6.37%
3 months
-36.84%
6 months
82.68%
Year to date
9.18%
1 year
-6.83%
5 years
-6.83%
10 years
-6.83%
 

About: Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

0
Funds holding %
of 7,407 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

0.86% more ownership

Funds ownership: 0% [Q3] → 0.86% (+0.86%) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for BDMD.

Financial journalist opinion

Based on 5 articles about BDMD published over the past 30 days

Neutral
PRNewsWire
5 days ago
Baird Medical Presents Advanced MWA Technology to UCLA Expert in China
NEW YORK , April 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") recently hosted Dr. Gary G.
Baird Medical Presents Advanced MWA Technology to UCLA Expert in China
Neutral
PRNewsWire
1 week ago
Baird Medical Advances Global Expansion of Microwave Ablation Technology
NEW YORK , April 9, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") recently announced a significant milestone in its international expansion.
Baird Medical Advances Global Expansion of Microwave Ablation Technology
Neutral
PRNewsWire
2 weeks ago
Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen
NEW YORK , April 2, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") proudly hosted Dr. Quan-Yang Duh, a world-renowned endocrine surgeon and Chief of Endocrine Surgery at the University of California, San Francisco (UCSF), for an in-depth clinical observation visit in Guangzhou and Shenzhen, China.
Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen
Neutral
PRNewsWire
2 weeks ago
Baird Medical's MWA Technology Successfully Applied in Endocrine Procedures
NEW YORK , March 31, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") proudly announces the successful utilization of its advanced microwave ablation (MWA) technology in two recent endocrine procedures.
Baird Medical's MWA Technology Successfully Applied in Endocrine Procedures
Neutral
PRNewsWire
3 weeks ago
Baird Medical Wins "Most Valuable Investment Award" for AI Tumor Ablation Surgical Robot
NEW YORK , March 24, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition, recognizing its groundbreaking AI Tumor Ablation Surgical Robot.
Baird Medical Wins "Most Valuable Investment Award" for AI Tumor Ablation Surgical Robot
Neutral
PRNewsWire
1 month ago
Baird Medical's AI Tumor Ablation Surgical Robot Wins "Most Valuable Investment Award," Pioneering AI and Robotics Integration in Healthcare
NEW YORK , March 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition with its revolutionary in-development product, the "AI Tumor Ablation Surgical Robot.
Baird Medical's AI Tumor Ablation Surgical Robot Wins "Most Valuable Investment Award," Pioneering AI and Robotics Integration in Healthcare
Neutral
PRNewsWire
1 month ago
Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology
NEW YORK , March 10, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, has received regulatory approval from the Indonesian Ministry of Health (Kementerian Kesehatan Republik Indonesia).
Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology
Neutral
PRNewsWire
1 month ago
Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, made a lasting impact at the 2025 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Lehi, Utah.
Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025
Neutral
PRNewsWire
1 month ago
Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou
NEW YORK , Feb. 26, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a leading innovator in microwave ablation (MWA) technology, continues to strengthen international medical collaboration.
Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou
Neutral
PRNewsWire
2 months ago
Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center
NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recently supported Dr. Hosai Todd-Hesham's participation in a specialized MWA training program at the Columbia Thyroid Center in New York City.
Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center
Charts implemented using Lightweight Charts™